EC Number | Application | Comment | Organism |
---|---|---|---|
3.1.1.47 | diagnostics | the enzyme is a positive risk factor for coronary disease and measurements of its amount may contribute to the prediction of coronary heart disease risk, especially in individuals with low LDL cholesterol levels | Homo sapiens |
EC Number | Cloned (Comment) | Organism |
---|---|---|
3.1.1.47 | gene maps to chromosome 6q12.p21.1 | Homo sapiens |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
3.1.1.47 | V279F | naturally occurring mutantion, ecspecially in Japanese population, loss of enzyme activity, associated with increased risk of stroke and of coronary artery disease | Homo sapiens |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
3.1.1.47 | extracellular | plasma | Homo sapiens | - |
- |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
3.1.1.47 | additional information | secretory isozyme is Ca2+-independent | Homo sapiens |
EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|---|
3.1.1.47 | 14000 | - |
x * 14000, secretory isozyme | Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.1.1.47 | 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine + H2O | Homo sapiens | i.e. platelet-activation factor | 1-alkyl-sn-glycero-3-phosphocholine + acetate | - |
? | |
3.1.1.47 | additional information | Homo sapiens | the plasma isozyme is associated with LDL, 80%, and HDL, 15-20%, and VLDL, below 5%, particles, where it seems to be independently regulated and to have distinct roles in artherosclerosis, LDL-associated enzyme has a protective role in artheriosclerosis, regulation of lipoprotein-associated enzyme in vivo, overview | ? | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.1.1.47 | Homo sapiens | - |
- |
- |
EC Number | Posttranslational Modification | Comment | Organism |
---|---|---|---|
3.1.1.47 | glycoprotein | N-glycosylation is essential | Homo sapiens |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.1.1.47 | artery wall | - |
Homo sapiens | - |
3.1.1.47 | macrophage | increased enzyme expression in artheriosclerosis | Homo sapiens | - |
3.1.1.47 | additional information | wide tissue distribution | Homo sapiens | - |
3.1.1.47 | plasma | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.1.1.47 | 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine + H2O | i.e. platelet-activation factor | Homo sapiens | 1-alkyl-sn-glycero-3-phosphocholine + acetate | - |
? | |
3.1.1.47 | additional information | lipoprotein-associated enzyme does not hydrolyse native phospholipids | Homo sapiens | ? | - |
? | |
3.1.1.47 | additional information | the plasma isozyme is associated with LDL, 80%, and HDL, 15-20%, and VLDL, below 5%, particles, where it seems to be independently regulated and to have distinct roles in artherosclerosis, LDL-associated enzyme has a protective role in artheriosclerosis, regulation of lipoprotein-associated enzyme in vivo, overview | Homo sapiens | ? | - |
? |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
3.1.1.47 | ? | x * 14000, secretory isozyme | Homo sapiens |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.1.1.47 | lipoprotein-associated phospholipase A2 | - |
Homo sapiens |
3.1.1.47 | Lp-PLA2 | - |
Homo sapiens |
3.1.1.47 | PAF acetylhydrolase | - |
Homo sapiens |
3.1.1.47 | platelet-activating factor acetylhydrolase | - |
Homo sapiens |